Novel HDAC inhibitors exhibit pre-clinical efficacy in lymphoma models and point to the importance of CDKN1A expression levels in mediating their anti-tumor response. Homo sapiens
收藏NIAID Data Ecosystem2026-03-07 收录
下载链接：
https://www.ncbi.nlm.nih.gov/bioproject/PRJNA271950
下载链接
链接失效反馈官方服务：
资源简介：
investigate the pre-clinical activities of two novel histone deacetylase inhibitors (HDACi), ITF-A and ITF-B, in a large panel of pre-clinical lymphoma models Overall design: GEP analysis of 2 lymphoma cell lines with and without treatment
创建时间：
2015-01-09
